-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a recent study published in Journal Of Neurology Neurosurgery And psychic, a group-based queue of patients with traumatic brain injury assessed the use of psychoprotectic and painkillers and compared them with controls from similar backgrounds.
researchers assessed data on patients diagnosed with brain trauma in hospitals or specialist clinics between 2006 and 2012.
were not diagnosed with brain trauma as a control.
assessed the use of psychotic and painkillers in the 12 months before and after traumatic brain injury.
researchers identified 23,425 patients with brain trauma and 199,658 unaffected controls.
36.6 percent of patients in the trauma brain injury population had taken at least one psychotic or painkiller in the 12 months prior to the traumatic brain injury.
12 months after brain damage, the drug use rate increased to 45.0%, an absolute increase of 8.4%.
use of post-brain trauma opioids (from 16.3 per cent to 21.6 per cent, p-lt;0.001) and non-opioid analgesics (from 20.3 per cent to 26.6 per cent and p-lt;0.001) increased the most.
prescriptions were short-term; opioid prescriptions accounted for 20.6 per cent and benzodiazepines for more than six months accounted for 37.3 per cent.
compared to the controls, patients with traumatic brain injuries were more likely to take any psychosophpathic or painkillers before trauma (OR: 1.62, 95% CI: 1.59-1.65) and post-traumatic injury (OR: 2.30, 95% CI: 2.26-2.34).
, it can be seen that the use of psychostated and painkillers after brain injury is high, it is recommended to conduct regular medical follow-up and summarize the use of these drugs.